ANDA 73683, held by Sandoz. Cyclobenzaprine Hydrochloride.
As of Nov 19, 2026, ANDA 73683 (Cyclobenzaprine Hydrochloride), held by Sandoz, was first approved by FDA on Feb 26, 1993, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 26, 1993 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Cyclobenzaprine Hydrochloride10MG · tablet;oral | Cyclobenzaprine Hydrochloride | Discontinued |
| Oct 30, 1997 | Supplement 4Manufacturing | Approved | None posted |
| Mar 30, 1995 | Supplement 1Manufacturing | Approved | None posted |
| Mar 30, 1995 | Supplement 2Labeling | Approved | None posted |
| Mar 30, 1995 | Supplement 3Manufacturing | Approved | None posted |
| Feb 26, 1993 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters